Drug Level Assays

Drug level assays play a critical role in pharmacokinetics and therapeutic drug monitoring (TDM), enabling healthcare professionals to assess drug concentrations in patient samples. These assays provide valuable insights into drug efficacy, safety, and individualized dosing regimens. By measuring drug levels accurately, clinicians can optimize treatment outcomes and minimize adverse effects.

Related Products

    076-20-TurbiPEL-Faecal-Pancreatic-Elastase-turbidimetric-assay

    Adalimumab Drug Level ELISA (IDKmonitor®)

    Adalimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Adalimumab Drug Level ELISA kit is a microplate-based quantitative sandwich ELISA for the determination of free therapeutic TNFα antibodies (adalimumab) from plasma or serum samples.

    Certolizumab Drug Level ELISA (IDKmonitor)

    Certolizumab Drug Level ELISA (IDKmonitor®)

    Determination of free therapeutic certolizumab

    Certolizumab is the Fab’ fragment of a recombinant humanised antibody conjugated to polyethylene glycol (PEG) and is therefore also known as “certolizumab pegol”. The IDKmonitor Certolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free certolizumab therapeutic drug in serum and EDTA plasma samples.

    076-20-Etanercept-Drug-Level-ELISA-IDKmonitor

    Etanercept Drug Level ELISA (IDKmonitor®)

    The innovative IDKmonitor Etanercept Drug Level ELISA is a microplate-based assay that allows quantitative determination of free etanercept from plasma or serum samples. Etanercept is a human therapeutic monoclonal antibody (mAb) used to monitor treatment for chronic rheumatic diseases such as rheumatoid arthritis.

    076-20-Golimumab-Drug-Level-ELISA-IDKmonitor

    Golimumab Drug Level ELISA (IDKmonitor®)

    Golimumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Golimumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free golimumab in plasma or serum samples.

    076-20-Infliximab-Drug-Level-ELISA-IDKmonitor

    Infliximab Drug Level ELISA (IDKmonitor®)

    Infliximab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Infliximab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free infliximab in plasma or serum samples.

    076-20-Rituximab-Drug-Level-ELISA-IDKmonitor

    Rituximab Drug Level ELISA (IDKmonitor®)

    The IDKmonitor Rituximab Drug Level ELISA kit is a microplate-based quantitative assay for the determination of free rituximab from plasma or serum samples. Rituximab is a chimeric therapeutic monoclonal antibody (mAb) that targets B-cells (CD-20) in the treatment of rheumatoid arthritis, non-Hodgkin’s B-cell lymphomas, lymphocytic leukaemia, active granulomatosis with polyangiitis and microscopic polyangiitis.

    076-20-Ustekinumab-Drug-Level-ELISA-IDKmonitor

    Ustekinumab Drug Level ELISA (IDKmonitor®)

    Ustekinumab is a recombinant protein used to treat inflammatory bowel disease (IBD). The IDKmonitor Ustekinumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free ustekinumab in plasma or serum samples.

    076-20-Vedolizumab-Drug-Level-ELISA-IDKmonitor

    Vedolizumab Drug Level ELISA (IDKmonitor®)

    Vedolizumab is a recombinant protein used to treat Crohn’s disease and ulcerative colitis. The IDKmonitor Vedolizumab Drug Level ELISA kit is a microplate-based quantitative enzyme linked immunosorbent assay (ELISA) for the determination of free vedolizumab in plasma or serum samples.